7900 E. UNION AVENUE, DENVER, CO
Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
Termination of Material Definitive Agreement - AYTU Biopharma, Inc.
Reports Fiscal 2026 Third Quarter Operational and Financial Results
Earnings Release
Reports Fiscal 2026 Second Quarter Operational and Financial Results
Reg. FD
Election of Directors and Appointment of Accounting Firm at Aytu Biopharma
Reports Fiscal 2026 First Quarter Operational and Financial Results
FY 2025
Q3
Q2
Q1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Direct Registration System
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership